Didier Blaise

Didier Blaise

UNVERIFIED PROFILE

Are you Didier Blaise?   Register this Author

Register author
Didier Blaise

Didier Blaise

Publications by authors named "Didier Blaise"

Are you Didier Blaise?   Register this Author

100Publications

2760Reads

40Profile Views

The impact of counseling on nutritional status among hematopoietic stem cell recipients: results of a randomized controlled trial.

Bone Marrow Transplant 2019 May 22;54(5):752-756. Epub 2018 Oct 22.

Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0366-3DOI Listing
May 2019

Single-Unit versus Double-Unit Umbilical Cord Blood Transplantation in Children and Young Adults with Residual Leukemic Disease.

Biol Blood Marrow Transplant 2019 Apr 29;25(4):734-742. Epub 2018 Oct 29.

Department of Pediatric Hematology-Oncology, APHM, Timone Hospital, Aix-Marseille University, Marseille, France; Department of Public Health -EA 3279 Research Unit, Marseille University Hospital, Aix-Marseille University, Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183064
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.10.016DOI Listing
April 2019

Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes.

Bone Marrow Transplant 2019 Mar 6;54(3):458-464. Epub 2018 Aug 6.

Shanghai Institute of Hematology, Department of Hematology, Blood and Marrow Transplantation Center, Collaborative Innovation Center of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, 18F/OPD Bldg 197 Rui Jin Road II, 200025, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0283-5DOI Listing
March 2019

Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant 2018 11 7;24(11):2224-2232. Epub 2018 Aug 7.

Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Tel Aviv University, Tel-Aviv, Israel; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.07.007DOI Listing
November 2018

Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality.

Bone Marrow Transplant 2018 10 27;53(10):1233-1241. Epub 2018 Apr 27.

GRRR-OH-Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0181-xDOI Listing
October 2018

Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years.

Bone Marrow Transplant 2018 09 9;53(9):1096-1104. Epub 2018 Mar 9.

Aix-Marseille Univ, INSERM, IRD, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM), Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0133-5DOI Listing
September 2018

Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant 2018 04 13;24(4):751-757. Epub 2017 Dec 13.

Division of Hematology, Chaim Sheba Medical Center, Tel-Hashomer and Sackler Medical School Tel-Aviv University, Tel Aviv, Israel; Acute Leukemia Working Party Office, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.12.776DOI Listing
April 2018

Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.

Biol Blood Marrow Transplant 2018 03 13;24(3):549-554. Epub 2017 Dec 13.

Department of Hematology, Institut Paoli-Calmettes, Marseille, France; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR 7258, Marseille, France; Medical Faculty, Aix-Marseille University, UM 105, Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.11.042DOI Listing
March 2018

T-cell-replete haploidentical transplantation in acute myeloid leukemia.

Exp Hematol 2018 02 17;58:5-16. Epub 2017 Nov 17.

Department of Hematology, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille University UM 105, Marseille, France; Centre de Recherche en Cancérologie de Marseille, Inserm, U1068, CNRS UMR 7258, Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2017.11.001DOI Listing
February 2018

Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

J Clin Oncol 2017 Oct 28;35(30):3425-3432. Epub 2017 Aug 28.

Carmen Martínez, Institute of Hematology and Oncology, Hospital Clínic; Carmen Canals, Banc de Sang i Teixits; Anna Sureda, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona; Jorge Gayoso, Hospital General Universitario Gregorio Marañón, Madrid; Arancha Bermúdez, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain; Carmen Martínez, Hervé Finel, Silvia Montoto, Peter Dreger, and Anna Sureda, European Society for Blood and Marrow Transplantation, Paris; Didier Blaise, Institut Paoli Calmettes, Marseille; Edouard Forcade, University Hospital of Bordeaux, Bordeaux; Ibrahim Yakoub-Agha, Centre Hospitalier Regional Universitaire de Lille, Lille Inflammation Research International Center, Institut National de la Santé et de la Recherche Médicale U995, Lille, France; Karl Peggs, University College London Cancer Institute; Michael Potter, The Royal Marsden Hospital; Silvia Montoto, St Bartholomew's Hospital, Barts Health National Health Service Trust, London; Stephen Robinson, Bristol Haematology and Oncology Centre, Bristol; Grant McQuaker, Gartnaval General Hospital, Glasgow; Adrian Bloor, Christie National Health Service Trust Hospital, Manchester, United Kingdom; Alida Dominietto, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Azienda Ospedaliera-Universitaria San Martino-IST, Genova; Luca Castagna, Istituto Clinico Humanitas; Paolo Corradini, Istituto Nazionale dei Tumori, Milan; Domenico Russo, University of Brescia, Brescia, Italy; Boris Afanasyev, First Pavlov State Medical University of St Petersburg, St Petersburg, Russia; Maija Itälä-Remes, Turku University Hospital, Turku, Finland; Christof Scheid, University of Cologne, Cologne; and Peter Dreger, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6869DOI Listing
October 2017

[Sport coaching for psychological and social recovery after hematological cancer: An innovative perspective].

Bull Cancer 2017 Oct 12;104(10):823-830. Epub 2017 Oct 12.

Centre de recherche en cancérologie (CRCM), Marseille, France; Aix-Marseille université (AMU), Marseille, France; Institut Paoli-Calmette, département d'oncologie, 232, boulevard Sainte-Marguerite, BP 156, 13273 Marseille cedex 9, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.08.006DOI Listing
October 2017

Treatment of Post-transplant Relapse of FLT3-ITD Mutated AML Using 5-Azacytidine and Sorafenib Bitherapy.

Clin Lymphoma Myeloma Leuk 2017 04 11;17(4):241-242. Epub 2017 Jan 11.

Hematology Department, Institut Paoli-Calmettes, Marseille, France; Aix Marseille Université, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.10.002DOI Listing
April 2017